Doctor profile · Federal record
Dr. Konstantinos Leventakos, M.D.
Medical Oncology Physician (CMS: Medical Oncology) · Hematology & Oncology Physician · Rochester, MN
- NPI 1326338070
- Accepts Medicare
- 21 yrs in practice
- Male
- Group practice
- No sanctions
Practice & contact
Operates at 2 locations .
- Primary practice
-
200 1St St Sw
Rochester, MN 559053017
(507) 284-2511 - Additional location
-
110 Irving St Nw, Dept of Internal Medicine
Washington, DC 200103017
(202) 877-8278
fax (202) 877-6292
Credentials & registration
- NPI registered
- April 2011 — 15 yrs on file
- Profile last updated
- July 21, 2022
- Year of graduation
- 2005 — 21 yrs since
- Specialty taxonomy
- 207RX0202X — NUCC code
- State license (1)
- Minnesota #57811
Federal sanctions & exclusions
No sanctions, exclusions or revocations on file
Checked against OIG LEIE on NPI 1326338070. Last verified May 11, 2026.Medicare procedures · 2023
Top services delivered
Total services
29,472
Distinct HCPCS
10
Medicare allowed
$701,200
| HCPCS | Description | Services | Patients | Avg allowed | |
|---|---|---|---|---|---|
J9271 |
Injection, pembrolizumab, 1 mg | 6,200 | 29 | $50 | |
J9299 |
Injection, nivolumab, 1 mg | 4,320 | 11 | $30 | |
J9267 |
Injection, paclitaxel, 1 mg | 3,740 | 20 | $0 | |
J9144 |
Injection, daratumumab, 10 mg and hyaluronidase-fihj | 3,603 | 21 | $47 | |
J1453 |
Injection, fosaprepitant, 1 mg | 3,600 | 23 | $0 | |
J9263 |
Injection, oxaliplatin, 0.5 mg | 3,600 | 11 | $0 | |
J9041 |
Injection, bortezomib, 0.1 mg | 968 | 25 | $4 | |
J2405 |
Injection, ondansetron hydrochloride, per 1 mg | 892 | 86 | $0 | |
J1100 |
Injection, dexamethasone sodium phosphate, 1 mg | 829 | 71 | $0 | |
96375 |
Injection of additional new drug or substance into vein | 213 | 101 | $16 |
In context: peer comparison
Among 30 peers in this city , average services per provider: 717. This provider delivers 41× the peer median.Open Payments
Industry payments received
All-time total
$7,670
Transactions
10
Manufacturers
4
| Payer (manufacturer) | Industry | Txns | Amount |
|---|---|---|---|
| Janssen Biotech, Inc. | 5 | $4,512.49 | |
| Amgen Inc. | 1 | $2,744.00 | |
| Daiichi Sankyo Inc. | 1 | $255.75 | |
| AstraZeneca UK Limited | 3 | $157.79 |
By nature of payment
Medicare Part D · 2023
Top prescriptions
Total claims
121
Patients
13
Total drug cost
$805,341
| Drug | Type | Claims | Patients | Total cost |
|---|---|---|---|---|
| Tagrisso (Osimertinib Mesylate) | Brand | 20 | 0 | $325,147 |
| Levothyroxine Sodium | Generic | 18 | 0 | $297 |
| Prochlorperazine Maleate | Generic | 18 | 13 | $240 |
| Alecensa (Alectinib Hcl) | Brand | 16 | 0 | $142,045 |
| Dexamethasone | Generic | 13 | 0 | $136 |
| Mekinist (Trametinib Dimethyl Sulfoxide) | Brand | 12 | 0 | $175,535 |
| Ondansetron Hcl | Generic | 12 | 0 | $144 |
| Tafinlar (Dabrafenib Mesylate) | Brand | 12 | 0 | $161,797 |
Hospital affiliations
Frequently asked questions
What is Dr. Konstantinos Leventakos's medical specialty?
Dr. Konstantinos Leventakos practices Medical Oncology Physician in Rochester, MN.
Where does Dr. Konstantinos Leventakos practice?
Dr. Konstantinos Leventakos practices at 200 1St St Sw, Rochester, MN 559053017. Office phone: 5072842511.
What is Dr. Konstantinos Leventakos's NPI?
Dr. Konstantinos Leventakos's National Provider Identifier (NPI) is 1326338070, issued by NPPES.
Does Dr. Konstantinos Leventakos accept Medicare assignment?
Yes. Dr. Konstantinos Leventakos accepts Medicare assignment, meaning Medicare-allowed amounts are accepted as full payment for covered services.
What procedures does Dr. Konstantinos Leventakos commonly perform?
Top Medicare-reported procedures in 2023: Injection, pembrolizumab, 1 mg (HCPCS J9271); Injection, nivolumab, 1 mg (HCPCS J9299); Injection, paclitaxel, 1 mg (HCPCS J9267). Source: CMS Medicare Physician & Other Practitioners file.